In a variety of tumors, including lung [141], liver [142], colorectal [143], and breast cancer [144,145,146], the expression of GAS5 is significantly decreased, suggesting that GAS5 might be a tumor-suppressing lncRNA. Here, GAS5 is linked to breast carcinoma.